These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3444030)
1. [Clinical study of carumonam]. Takebe K; Tamura T; Endo K; Irie T; Sekino K; Uehara O; Sagara M; Okamoto K Jpn J Antibiot; 1987 Nov; 40(11):1917-22. PubMed ID: 3444030 [TBL] [Abstract][Full Text] [Related]
2. [Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies]. Shimazaki C; Inaba T; Murakami S; Oku N; Itoh K; Ura Y; Nakagawa M; Fujita N Jpn J Antibiot; 1990 Aug; 43(8):1402-6. PubMed ID: 2283708 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection]. Sonoda T; Nakano E; Seguchi T; Yano H; Kuroda H; Ihara Y; Kishimoto T; Takatera H; Mizutani S; Iwao N Hinyokika Kiyo; 1991 Feb; 37(2):203-9. PubMed ID: 2048503 [TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection]. Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570 [TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of carumonam in chronic respiratory infections: double-blind study using cefoperazone as a positive control]. Shimada K; Kawakami Y; Abe S; Saito A; Nakayama I; Tomizawa M; Suzuki A; Onodera T; Yasuda N; Koroku T Kansenshogaku Zasshi; 1987 Mar; 61(3):333-55. PubMed ID: 3112288 [No Abstract] [Full Text] [Related]
6. [Clinical evaluation of astromicin by intravenous drip infusion. Report I. Bacterial infections in the field of internal medicine]. Hara K; Saito A; Shigeno Y; Kohno S; Ishikawa K; Kato Y; Kikuchi K; Yamamoto A; Hiraga Y; Oizumi K Jpn J Antibiot; 1986 Nov; 39(11):2926-37. PubMed ID: 3820571 [TBL] [Abstract][Full Text] [Related]
7. Carumonam versus ceftazidime for urinary tract infections. Edelstein H; Oster S; Cassano K; McCabe R Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefoperazone in lower respiratory tract infections]. Ishibashi T; Takamoto M; Shinoda A; Matsuba K; Yoshida M; Ichikawa Y; Ando M; Matsuzaki Y; Kitahara Y; Hara N Jpn J Antibiot; 1986 Oct; 39(10):2780-94. PubMed ID: 3543433 [TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of sulbactam/cefoperazone for the treatment of geriatric patients with respiratory tract infections]. Takaki K; Umeno M; Tanaka M; Harashima S; Takeda T; Okada K; Sawae Y Jpn J Antibiot; 1995 Jul; 48(7):942-8. PubMed ID: 7563587 [TBL] [Abstract][Full Text] [Related]
10. [Clinical studies on azithromycin in pediatrics]. Okamoto T; Sekiguchi T Jpn J Antibiot; 1996 Oct; 49(10):939-46. PubMed ID: 8986557 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of sultamicillin in lower respiratory tract infections]. Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Miyazaki N; Matsuzaki Y Jpn J Antibiot; 1991 Feb; 44(2):150-9. PubMed ID: 2041156 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo experience with carumonam: a preliminary report. Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections]. Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054 [TBL] [Abstract][Full Text] [Related]
16. [Bacterial combination effect between carumonam and eight other antibiotics]. Obana Y; Murakami T; Kuzui H; Nishino T Jpn J Antibiot; 1990 Dec; 43(12):2094-101. PubMed ID: 2128341 [TBL] [Abstract][Full Text] [Related]
17. [Clinical study of aztreonam on respiratory tract infections caused by gram-negative pathogens]. Shimokata K; Totani Y; Morishita M; Hashigami H; Yamamoto M; Suetsugu S; Tanaka A; Umeda H; Sakai S; Kobayashi T Jpn J Antibiot; 1985 Nov; 38(11):3415-33. PubMed ID: 3912526 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group]. Fuji R; Hashira S; Tajima T; Meguro H; Abe T; Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients]. Toyonaga Y; Ishihara T; Nakamura H Jpn J Antibiot; 1996 Nov; 49(11):981-93. PubMed ID: 8988410 [TBL] [Abstract][Full Text] [Related]
20. [Clinical study on sulbactam/ampicillin in the pediatric field]. Takeda E; Hosoda T; Ichioka T; Miyao M Jpn J Antibiot; 1989 Mar; 42(3):725-31. PubMed ID: 2746852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]